Jonathan Deitch, MD
Vascular Surgery · Fort Worth, TXNPI 1679551469
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $11,126 of the $12,826 with a category attached, or 86.7%. 39 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 30.7% of the total.
Across 211 payments — averaging $60.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$4K
- Medtronic$3K
- Cook Medical LLC$775
- Endologix LLC$763
- Silk Road Medical, Inc.$617
- Penumbra, Inc.$527
- plus $3K from 33 others
Across 18 payments — averaging $1326.92 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- W. L. Gore & Associates, Inc.$12K
- Boston Scientific$12K
What the payments were for
- Grants$4393%
- Travel & lodging$1,26210%
- Food & beverage$11,12687%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 41 | $3,943 |
| Medtronic(2 entities) | 29 | $2,774 |
| Cook Medical LLC | 7 | $775 |
| Endologix LLC | 7 | $763 |
| Silk Road Medical, Inc. | 13 | $617 |
| Penumbra, Inc. | 5 | $527 |
| Boston Scientific | 13 | $502 |
| Abbott | 8 | $350 |
| Lemaitre Vascular, Inc. | 10 | $271 |
| Stryker | 8 | $244 |
| Teleflex LLC | 4 | $210 |
| Bard Peripheral Vascular, Inc. | 3 | $204 |
| Shockwave Medical, Inc | 5 | $148 |
| Tactile Systems Technology Inc | 6 | $129 |
| Acera Surgical, Inc. | 7 | $126 |
| Johnson & Johnson(2 entities) | 5 | $123 |
| Cardiovascular Systems Inc. | 1 | $121 |
| Bolton Medical Inc | 3 | $116 |
| Kerecis Limited | 5 | $88 |
| Artivion, Inc. | 2 | $87 |
| Davol Inc. | 3 | $85 |
| Truvic Medical, Inc. | 2 | $82 |
| Viz.ai, Inc. | 1 | $71 |
| BD | 2 | $64 |
| Argon Medical Devices, Inc. | 3 | $58 |
| Angiodynamics, Inc. | 4 | $57 |
| Laminate Medical Technologies Inc. | 1 | $39 |
| Axogen | 2 | $32 |
| Integra Lifesciences Corporation | 1 | $31 |
| Innovation Technologies Inc | 1 | $23 |
| AstraZeneca | 1 | $23 |
| Cordis US CORP. | 1 | $22 |
| Surmodics, Inc. | 1 | $21 |
| Terumo Medical Corporation | 1 | $20 |
| Mimedx Group, Inc. | 1 | $19 |
| Reprise Biomedical, Inc. | 1 | $17 |
| Neuros Medical, Inc. | 1 | $16 |
| Sanara Medtech Inc. | 1 | $14 |
| Ossur Americas, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$959
- ENDURANT IIS$836
- Valiant Captivia$701
- Alto Abdominal Stent Graft System$565
- GORE TAG Thoracic Endoprosthesis$552
- GORE TAG Thoracic Branch Endoprosthesis$524
- ENROUTE Transcarotid Stent$493
- ENROUTE Transcarotid Neuroprotection System$493
- Endurant$470
- EXCLUDER AAA Endoprosthesis$341
- Cook Medical Thoracic$237
- GORE EXCLUDER AAA Endoprosthesis$192
- VIABAHN VBX Balloon Expandable Endoprosthesis$191
- RUBY Coil$175
- ENROUTE .014 Guidewire$174
- ENHANCE Transcarotid Peripheral Access Kit$174
- Penumbra System$166
- GORE VIABAHN Endoprosthesis with Heparin$148
- Indigo System$142
- MANTA$141
How this compares
$12,826 in reported general payments places this provider in the 65th percentile of 347 vascular surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $100 |
| ClopidogrelClopidogrel Bisulfate | 14 | $57 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Fort Worth
- Johnna JonesFort Worth$90K
- Atish ChopraFort Worth$55K
- Gregory PearlDallas$2.3M
- Mazin FotehAustin$1.6M
- Alan LumsdenHouston$742K
- Stephen HohmannDallas$499K
- Michael SiahDallas$392K
- Gustavo OderichHouston$319K
- Jean BismuthHouston$243K
- Carlos TimaranDallas$231K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.